HER2 Positive Breast Cancer : Reviewing Abstracts Published by Authors Shanu Modi, Shanu Modi & Guy Jerusalem
HER2 Positive Breast Cancer
Speaker :
Dr. Aditya Murali, Medical Oncologist, Bangalore
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
Author: Shanu Modi
Citation: N Engl J Med 2020; 382:610-621
Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase IB Study
Author: Shanu Modi
Citation: J Clin Oncol. 2020 Jun 10;38(17):1887-1896
CNS metastases in HER2-positive metastatic breast cancer treated with trastuzumab deruxtecan: DESTINY-Breast01 subgroup analyses
Author: Guy Jerusalem
Citation: Annals of Oncology (2020) 31 (suppl_2): S62-S82
10.1016/annonc/annoc122x